Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide versus premixed insulin for carotid intima-media thickness in type 2 diabetes
ChiCTR-IPR-15006008Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Jan 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Exenatide with Insulin (2 arms). Primary endpoint: Change in carotid intima-media thickness. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
exenatidehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-15006008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006008.